• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

When "Wonderful New Technologies" Fail...

  • Fri, 9/5/08 - 3:36pm
  • 0 Comments
  • 1911 reads
Author(s): 

Frank J. Criado, MD

After completing a review of the article “Management of Detached Accunet…” by Chane et al., I found myself wanting to add something personal, a commentary. So I did, but it wasn’t enough. I therefore decided to reflect further upon our field’s “wonderful new technologies” and use this topic as the foundation for this month’s Editor’s Corner.

Just think about it: this is one of “the most perfect issues” for VDM readers. The use of new technologies, with a growing reliance, if not dependence, on innovative devices, is at the very center of who we have all become! Carotid intervention, aortic endografts and many other such things are great examples of how interventional medicine has changed in the span of only two or three decades. Procedures are no longer about “a surgeon and his tools” — tools that used to be fairly simple, even “rudimentary,” and in existence (essentially) since the ancestral beginnings of our craft.

Almost everything has changed. With the 1980’s as the fundamental starting point, our armamentarium has since incorporated a vast array of new tools and techniques, almost too many to remember. New paradigms have entered into our thinking and decision-making. We often find ourselves at the mercy of “clinical specialists” who have to “guide us” through the use of new devices, troubleshooting and the like. It is a whole new world indeed! And a bumpy road, full of potential obstacles, even peril.

Carotid stent intervention (CAS) is perhaps the best metaphor for what is happening. These “wonderful new technologies” have revolutionized who we are and what we do, but they have also added layers of complexity and potential failure and pitfall. To those interventional physicians who have not yet seen any of this, let me just say –— categorically — that you undoubtedly will as your experience grows. And then, you will understand how incredibly helpful having read (and remembering) an article such as the one from Chane et al. can be when resolving such a problem. We should feel indebted to our colleagues who are willing to share with us some of their darkest interventional moments, along with the important lessons that we often derive from such nightmarish scenarios. These communications are often more practically meaningful than the abundant reports on the many triumphs generated by such new technologies.

image description image description

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
  • Robotic-Assisted Pci Procedures Using Corpath 200 System Will Be Discussed During CRT2012 Conference
    Tue, 02/07/12 - 10:00am
  • Vascular Solutions Launches Reprocessing Service For Closurefast Vein Catheters
    Fri, 02/03/12 - 1:14pm
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications